Apg Asset Management N.V. Corcept Therapeutics Inc Transaction History

Apg Asset Management N.V.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$24.82 - $32.88 $295,358 - $391,272	-11,900 Reduced 51.97%	11,000 $357,000
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $503,113 - $774,019	22,900 New	22,900 $624,000
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $93,765 - $140,812	4,700 Added 8.35%	61,000 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $1.39 Million - $1.64 Million	56,300 New	56,300 $1.47 Million
Q4 2021 Feb 11, 2022	SELL	$17.1 - $23.34 $704,844 - $962,051	-41,219 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $2.06 Million - $2.36 Million	-104,800 Reduced 71.77%	41,219 $700,000
Q2 2021 Aug 13, 2021	SELL	$19.97 - $24.43 $918,620 - $1.12 Million	-46,000 Reduced 23.96%	146,019 $2.71 Million
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $1.12 Million - $1.83 Million	67,000 Added 53.59%	192,019 $4.11 Million
Q3 2020 Nov 12, 2020	BUY	$12.46 - $19.98 $1.17 Million - $1.88 Million	94,000 Added 303.04%	125,019 $1.86 Million
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $341,209 - $566,406	31,019 New	31,019 $465,000

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.